The Benefits of Using Continuous Glucose Monitoring to Diagnose Type 1 Diabetes.
作者信息
Ayers Alessandra T, Ho Cindy N, Wong Jenise C, Kerr David, Mader Julia K, Klonoff David C
机构信息
Diabetes Technology Society, Burlingame, CA, USA.
Division of Endocrinology, Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA.
出版信息
J Diabetes Sci Technol. 2024 Oct 12:19322968241288923. doi: 10.1177/19322968241288923.
Abstract
摘要
相似文献
1
The Benefits of Using Continuous Glucose Monitoring to Diagnose Type 1 Diabetes.
J Diabetes Sci Technol. 2024 Oct 12:19322968241288923. doi: 10.1177/19322968241288923.
2
Exploring Minimally Invasive Approach to Define Stages of Type 1 Diabetes Remotely.
Diabetes Technol Ther. 2022 Sep;24(9):655-665. doi: 10.1089/dia.2021.0554. Epub 2022 Jun 20.
3
Predicting Immunological Risk for Stage 1 and Stage 2 Diabetes Using a 1-Week CGM Home Test, Nocturnal Glucose Increments, and Standardized Liquid Mixed Meal Breakfasts, with Classification Enhanced by Machine Learning.
Diabetes Technol Ther. 2023 Sep;25(9):631-642. doi: 10.1089/dia.2023.0064. Epub 2023 Jun 15.
4
OGTT Metrics Surpass Continuous Glucose Monitoring Data for T1D Prediction in Multiple-Autoantibody-Positive Individuals.
J Clin Endocrinol Metab. 2023 Dec 21;109(1):57-67. doi: 10.1210/clinem/dgad472.
5
Discrimination and Precision of Continuous Glucose Monitoring in Staging Children With Presymptomatic Type 1 Diabetes.
J Clin Endocrinol Metab. 2025 May 19;110(6):1624-1632. doi: 10.1210/clinem/dgae691.
6
Glycemic Outcomes and Feature Set Engagement Among Real-Time Continuous Glucose Monitoring Users With Type 1 or Non-Insulin-Treated Type 2 Diabetes: Retrospective Analysis of Real-World Data.
JMIR Diabetes. 2023 Jan 18;8:e43991. doi: 10.2196/43991.
7
Continuous glucose monitoring has an increasing role in pre-symptomatic type 1 diabetes: advantages, limitations, and comparisons with laboratory-based testing.
Clin Chem Lab Med. 2023 Jun 23;62(1):41-49. doi: 10.1515/cclm-2023-0234. Print 2024 Jan 26.
8
The continuous spectrum of glycaemic variability changes with pancreatic islet function: A multicentre cross-sectional study in China.
Diabetes Metab Res Rev. 2022 Nov;38(8):e3579. doi: 10.1002/dmrr.3579. Epub 2022 Oct 25.
9
Diabetes technology and treatments in the paediatric age group.
Int J Clin Pract Suppl. 2011 Feb(170):76-82. doi: 10.1111/j.1742-1241.2010.02582.x.
10
Dynamics of Hemoglobin A1c, Body Mass Index, and Rates of Severe Hypoglycemia in 4434 Adults with Type 1 or Type 2 Diabetes After Initiation of Continuous Glucose Monitoring.
Diabetes Technol Ther. 2022 Oct;24(10):763-769. doi: 10.1089/dia.2022.0063. Epub 2022 Jul 8.
引用本文的文献
1
The Use of Continuous Glucose Monitoring to Diagnose Stage 2 Type 1 Diabetes.
J Diabetes Sci Technol. 2025 May 30:19322968251333441. doi: 10.1177/19322968251333441.
2
Practical Approaches to Continuous Glucose Monitoring in Primary Care: A UK-Based Consensus Opinion.
Diabetes Ther. 2025 Apr;16(4):749-762. doi: 10.1007/s13300-025-01706-x. Epub 2025 Feb 28.
本文引用的文献
1
Hyperglycemic Crises in Adults With Diabetes: A Consensus Report.
Diabetes Care. 2024 Aug 1;47(8):1257-1275. doi: 10.2337/dci24-0032.
2
Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes.
Diabetes Care. 2024 Aug 1;47(8):1276-1298. doi: 10.2337/dci24-0042.
3
Global, regional, and national burden of type 1 diabetes in adolescents and young adults.
Pediatr Res. 2025 Feb;97(2):568-576. doi: 10.1038/s41390-024-03107-5. Epub 2024 Mar 5.
4
OGTT Metrics Surpass Continuous Glucose Monitoring Data for T1D Prediction in Multiple-Autoantibody-Positive Individuals.
J Clin Endocrinol Metab. 2023 Dec 21;109(1):57-67. doi: 10.1210/clinem/dgad472.
5
Teplizumab: First Approval.
Drugs. 2023 Apr;83(5):439-445. doi: 10.1007/s40265-023-01847-y.
6
CGM Metrics Identify Dysglycemic States in Participants From the TrialNet Pathway to Prevention Study.
Diabetes Care. 2023 Mar 1;46(3):526-534. doi: 10.2337/dc22-1297.
7
Exploring Minimally Invasive Approach to Define Stages of Type 1 Diabetes Remotely.
Diabetes Technol Ther. 2022 Sep;24(9):655-665. doi: 10.1089/dia.2021.0554. Epub 2022 Jun 20.
8
Benefits and Drawbacks of Continuous Glucose Monitoring (CGM) Use in Young Children With Type 1 Diabetes: A Qualitative Study From a Country Where the CGM Is Not Reimbursed.
J Patient Exp. 2021 Dec 2;8:23743735211056523. doi: 10.1177/23743735211056523. eCollection 2021.
9
CGM Metrics Predict Imminent Progression to Type 1 Diabetes: Autoimmunity Screening for Kids (ASK) Study.
Diabetes Care. 2022 Feb 1;45(2):365-371. doi: 10.2337/dc21-0602.
10
Delayed referral is common even when new-onset diabetes is suspected in children. A Swedish prospective observational study of diabetic ketoacidosis at onset of Type 1 diabetes.
Pediatr Diabetes. 2021 Sep;22(6):900-908. doi: 10.1111/pedi.13229. Epub 2021 Jun 16.
Zotero 插件